Atlas Trials

Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei

Clinical trial NCT04982146 · UNKNOWN

Trial details

NCT number
NCT04982146
Sponsor
Maimónides Biomedical Research Institute of Córdoba
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Pseudomyxoma Peritonei
Start date
2021-09-13
Primary completion
2022-05-16
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.